Keyphrases
Multidrug-resistant Tuberculosis (MDR-TB)
99%
Tuberculosis Patients
93%
Indonesia
86%
Surabaya
86%
COVID-19
73%
COVID-19 Patients
67%
Indonesian
58%
Type 2 Diabetes Mellitus (T2DM)
57%
Antibiotics
55%
Bedaquiline
54%
Type 1 Diabetes Mellitus (T1DM)
53%
Medical Records
48%
Inclusion Criteria
43%
Type 2 Diabetic Patients
43%
QTc Interval
43%
QT Prolongation
41%
Glycemic Control
40%
Interleukin-6
40%
Rifampicin-resistant Tuberculosis
40%
Antibiotic Use
40%
Risk Factors
40%
Medication Adherence
36%
Blood Glucose
34%
Body Mass Index
34%
Insulin Therapy
33%
Anticoagulants
33%
Drug Use
31%
Drug-related Problems
30%
Delamanid
30%
Scoping Review
30%
Stress Ulcer Prophylaxis
30%
Prophylactic Antibiotics
30%
Chronic Kidney Disease
30%
Fluvoxamine
30%
Quercetin
30%
Lopinavir
30%
Teaching Hospital
29%
C-reactive Protein
28%
Atorvastatin
28%
Azithromycin
27%
General Hospital
27%
Adverse Drug Reaction
27%
Moxifloxacin
26%
Chemotherapy
26%
Osteoarthritis
25%
Quality of Life
25%
Enoxaparin
25%
Warfarin
25%
Monotherapy
25%
Drug Combination
24%
MRNA Expression
24%
Morphine
23%
Surgical Site Infection
23%
Matrix metalloproteinase-9 (MMP-9)
23%
Stress-induced Gastric Ulcer
22%
Inflammatory Markers
22%
TB Patients
22%
AIDS/HIV
22%
Phenytoin
22%
Inflammatory Cytokines
21%
Constipation
21%
Geriatric Patients
21%
Mortality Prediction
21%
East Java Indonesia
21%
Cancer Patients
21%
Pediatric Patients
21%
Bronchodilator
21%
COVID-19 Pandemic
20%
Cost Analysis
20%
Tumor Lysis Syndrome
20%
Kidney Function
20%
Heart Failure Patients
20%
Nicotine
20%
Burn Patients
20%
Aquaporin-3 (AQP3)
20%
Hydroxychloroquine
20%
Potentially Inappropriate Medication
20%
Public Hospitals
20%
Primary Healthcare Centers
20%
Andrographolide
20%
Knee Osteoarthritis
20%
Lipid Profile
20%
Hepatic Cirrhosis
20%
Corrected QT Interval
20%
Self-medication
20%
Diuretics
20%
Glutaraldehyde
20%
Non-Hodgkin Lymphoma
20%
Drug Interactions
20%
Inflammation
20%
Intensive Phase
20%
University Hospital
19%
Continuation Phase
18%
D-dimer
18%
Universitas
18%
Hypertension
17%
Adult Patients
16%
Sampling Methods
16%
Bronchodilator Therapy
16%
Patient Adherence
16%
Pharmacology, Toxicology and Pharmaceutical Science
Diseases
100%
Drug Resistant Tuberculosis
81%
Diabetes Mellitus
77%
Retrospective Study
74%
Antibiotics
63%
Non Insulin Dependent Diabetes Mellitus
62%
Interleukin 6
53%
Bedaquiline
47%
Side Effect
43%
Coronavirinae
41%
Gelatinase B
39%
Adverse Drug Reaction
39%
Messenger RNA
38%
Anticoagulant Agent
36%
Chronic Kidney Failure
33%
Atorvastatin
33%
Observational Study
33%
Cross-Sectional Study
32%
Stress Ulcer
31%
Delamanid
30%
Rifampicin
30%
Dyslipidemia
30%
Fluvoxamine
30%
Quercetin
30%
Lopinavir Plus Ritonavir
30%
Hemoglobin A1c
30%
Moxifloxacin
27%
Azithromycin
27%
Biological Marker
27%
Infection
27%
Isotopes of Potassium
27%
Hemodialysis
26%
Stomach Ulcer
26%
Glycosylated Hemoglobin
25%
Combination Drug
24%
Monotherapy
23%
Morphine
23%
Cytokine
23%
Inflammation
23%
Pandemic
23%
Enoxaparin
22%
Warfarin
22%
Prevalence
22%
Phenytoin
21%
Constipation
21%
Polypharmacy
21%
HIV
21%
Bronchodilating Agent
21%
Chemotherapy
21%
Drug Interaction
20%
Antidiabetic Agent
20%
Tumor Lysis Syndrome
20%
Self-Medication
20%
Andrographolide
20%
Coronary Artery Disease
20%
Burn
20%
Liver Cirrhosis
20%
Chronic Obstructive Lung Disease
20%
Hydroxychloroquine
20%
Multi-Drug-Resistant Tuberculosis
20%
Glutaraldehyde
20%
Statin (Protein)
20%
C Reactive Protein
20%
D Dimer
18%
Diuretics
18%
Surgical Infection
17%
Gelatin
17%
Escherichia coli
16%
Hydroxyapatite
16%
Brain Ischemia
16%
Cardiovascular Disease
16%
Pharmacokinetics
15%
Malignant Neoplasm
15%
Levofloxacin
15%
Medication Error
15%
Short Acting Insulin
15%
Cigarette Smoke
15%
Cerebrovascular Accident
15%
Nonhodgkin Lymphoma
15%
Metabolic Disorder
15%
Tissue Inhibitor of Metalloproteinase
15%
Captopril
15%
Cohort Study
14%
1,1 Dichloro 2,2 Bis(4 Chlorophenyl)ethane
14%
Antihypertensive Agent
13%
Asthma
13%
Doxycycline
13%
Allopurinol
13%
Paracetamol
13%
Proton Pump Inhibitor
13%
Amoxicillin
13%
Clinical Study
13%
Mortality Rate
13%
Comorbidity
12%
Tumor Necrosis Factor
12%
Fondaparinux
12%
Brain Injury
12%
Linezolid
12%
Prospective Cohort Study
12%
Treatment Group
12%